Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 266
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
UK Set to Become Hub of Psychedelic Research, as British Startup...
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year...
Wesana Health Partners with University of South Carolina
Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has...
Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board
Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief...
Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production...
Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic...
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic...
Load more